Tofflon Science and Technology Group Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Dongfulong Technology Group Co., Ltd. (SZ: 300171) was established in 1993. It is a comprehensive pharmaceutical equipment service provider that provides pharmaceutical processes, core equipment, and system engineering solutions for global pharmaceutical enterprises. Its products are used in fields such as injections, solid formulations, chemical raw materials, bioengineering, traditional Chinese medicine, healthcare, and food. There are over 10000 critical pharmaceutical equipment for sterile injections, and over 600 sterile drug manufacturing systems serving nearly 3000 pharmaceutical companies in over 40 countries and regions worldwide. Today, Dongfulong focuses on research in pharmaceutical manufacturing science and pharmaceutical machinery manufacturing, practicing the integration and innovation of pharmaceutical equipment and pharmaceutical processes, gathering global technology, possessing five modern equipment production bases with global competitiveness, and gradually establishing global design and research and development centers overseas, Collaborate with global advanced technology enterprises to provide valuable pharmaceutical manufacturing equipment and system solutions for the development of pharmaceutical enterprises today and even in the future. In the future, Dongfulong adheres to the mission of "professional technology serving biopharmaceuticals", focuses on the challenges and pressures that the pharmaceutical industry pays attention to, explores "innovative drug manufacturing models", creates "advanced drug manufacturing platforms", and is committed to growing from "China's Dongfulong" to "the world's Dongfulong", from "system solution service provider" to "delivery provider of smart pharmaceutical factories", serving the global pharmaceutical industry. While focusing on the compulsory medicine industry, we strive to develop medical technology and food engineering, and strive tirelessly to maximize the happiness of society, customers, shareholders, employees, and their families. We contribute our wisdom and strength to serving the cause of human health. |
| Headquarter | Shanghai |
| Establish Date | 12/25/1993 |
| Listed Code | 300171.SZ |
| Listed Date | 2/1/2011 |
| Chairman | Zheng Xiaodong. |
| CEO | Zheng Xiaodong. |
| Website | www.tofflon.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
